
Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Description
Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
An Spinal Cord Stimulators (SCS) is a device that comprises a surgically implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Spinal Cord Stimulators (SCS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
179 Pages
- Spinal Cord Stimulators (SCS) Overview
- Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
- Spinal Cord Stimulators (SCS) - Pipeline Products by Segment
- Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
- Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
- Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
- Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
- Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
- Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
- Beijing Leading Medical Valley Technology Development Co Ltd Company Overview
- Beijing Lingchuang Yigu Technology Development Co Ltd Company Overview
- Beijing Xinyun Medical Technology Co Ltd Company Overview
- Boston Scientific Corp Company Overview
- Cerevast Therapeutics Inc Company Overview
- Cosyma Company Overview
- Direct Spinal Therapeutics, Inc. Company Overview
- Duke University Company Overview
- Hangzhou Shenluo Medical Technology Co Ltd Company Overview
- Imperial College London Company Overview
- Lawson Health Research Institute Company Overview
- Meagan Medical Inc. Company Overview
- Medtronic Plc Company Overview
- Micro-Leads Inc Company Overview
- MicroTransponder Inc Company Overview
- Neuronoff Inc Company Overview
- NeuroOne Medical Technologies Corp Company Overview
- Nevro Corp Company Overview
- Nexstim Plc Company Overview
- Onward Medical NV Company Overview
- Onward Technologies Ltd Company Overview
- Quantum Nanostim LLC Company Overview
- Reach Neuro Inc Company Overview
- Rowan University Company Overview
- Saluda Medical Pty Ltd Company Overview
- Soin Neuroscience Inc Company Overview
- Soterix Medical Inc Company Overview
- SpineX Inc Company Overview
- Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
- St. Jude Medical LLC Company Overview
- Stimdia Medical Inc Company Overview
- SynerFuse Inc Company Overview
- Teliatry Inc Company Overview
- University of California Los Angeles Company Overview
- University of Cambridge Company Overview
- University of Illinois at Chicago Company Overview
- University of Minnesota Company Overview
- Wavegate Corp Company Overview
- WISE s.r.l. Company Overview
- Jun 04, 2024: Nalu PNS System Achieves Significant and Durable Pain Reduction, Meeting the Primary Endpoint of the COMFORT RCT Study
- Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
- Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
- May 28, 2024: WVU Researchers Develop 3D Model to Better Treat Neurological Disorders
- May 20, 2024: Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD ARC-EX Therapy
- May 09, 2024: `Wraparound' Implants Represent New Approach to Treating Spinal Cord Injuries
- Apr 26, 2024: Medtronic Receives FDA Approval for Inceptiv Closed-Loop Spinal Cord Stimulator
- Apr 25, 2024: ONWARD Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
- Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
- Apr 23, 2024: Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study)
- Apr 10, 2024: Cigna and EviCore Add Positive Coverage for the Evoke System
- Apr 09, 2024: SpineX eyes FDA submission as neurogenic bladder trial hits milestone
- Apr 02, 2024: ONWARD Medical Submits De Novo Application to FDA for its ARC-EX System
- Mar 22, 2024: VA Stand Act Introduced in the United States Senate
- Mar 19, 2024: Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation System
- Mar 19, 2024: Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up
- Mar 18, 2024: ONWARD's ARC-EX System advances towards commercial launch
- Mar 12, 2024: Mainstay Medical Announces Publication of Clinical Results Comparing Older Patients and Younger Patients
- Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
- Feb 29, 2024: Onward Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) From US FDA
- Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
- Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
- Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
- Feb 13, 2024: Mainstay Medical's ReActiv8 MRI labelling secures FDA approval
- Feb 07, 2024: FDA approves Boston Scientific's WaveWriter SCS Systems
- Feb 07, 2024: Onward Medical Announces Presentation at Biocapital Europe
- Feb 07, 2024: Onward Medical Announces Presentation at Biocapital Europe
- Feb 01, 2024: Neuronoff Announces Successful First-in-Human Study of Injectrode Technology for Chronic Pain
- Feb 01, 2024: Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
- Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
- Jan 29, 2024: Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
- Jan 25, 2024: ONWARD ARC Therapy Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
- Jan 23, 2024: Nalu Medical Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024
- Jan 23, 2024: Nalu Medical Presents Long-Term and Holistic Outcomes From the COMFORT RCT for PNS at NANS 2024
- Jan 22, 2024: ONWARD to Participate in Basel Healthtech Conference 2024
- Jan 20, 2024: Boston Scientific Presents Key Data at the 2024 North American Neuromodulation Society Meeting
- Jan 19, 2024: ONWARD to Participate in Degroof Petercam Healthcare Conference
- Jan 18, 2024: ONWARD Announces Start of HemON NL Clinical Study
- Jan 18, 2024: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
- Jan 18, 2024: Abbott's Proclaim Drg Neurostimulation System Offers Expanded MRI Access for People Suffering From Chronic Pain
- Jan 18, 2024: Revolutionizing Spine Surgery Techniques: Inspan Publishes First L5-S1 Spinal Fixation Research for Degenerative Disc and Stenosis in Premier Spine Surgery Journal
- Jan 17, 2024: Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting
- Jan 16, 2024: Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting
- Jan 10, 2024: Nevro Laying Off 63 People To Strengthen Financial Position
- Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
- Jan 03, 2024: SpineX Announces Successful in-Human Results to Treat Adults with Cerebral Palsy
- Nov 29, 2023: Nalu Medical, Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal
- Nov 20, 2023: Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
- Nov 10, 2023: Medtronic Announces 12-Month Study Results Showing DTM Spinal Cord Stimulation Programming Provides Long-Term, Significant Pain Relief for Indicated Chronic Back Pain Patients Not Eligible for Spine Surgery
- Nov 09, 2023: SpineX Demonstrates Ground Breaking Technology to Improve Bladder Function in Stroke Survivors
- Nov 06, 2023: Nature Medicine Publication Highlights Potential for ONWARD ARC Therapy to Improve Mobility After Parkinson's Disease
- Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
- Oct 17, 2023: Enrollment Completed in Synerfuse Proof-Of-Concept Study
- Oct 11, 2023: Boston Scientific Receives FDA Approval of Spinal Cord Stimulation Therapy for People Living with Diabetic Peripheral Neuropathy
- Oct 11, 2023: ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
- Oct 05, 2023: Newly Published Data Supports Effectiveness of BIOTRONIK Neuro's RESONANCE Stimulation
- Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
- Oct 04, 2023: Nevro to Report Third Quarter 2023 Financial Results
- Oct 03, 2023: Stimdia Medical Initiates FDA Approved IDE Pivotal Trial to Investigate Impact of Neuromuscular Stimulation on Mechanically Ventilated Patients
- Sep 27, 2023: ONWARD Announces First-in-Human Implant of ARC-IM Stimulator with Brain-Computer Interface (BCI) to Restore Arm, Hand, and Finger Function after Spinal Cord Injury
- Sep 26, 2023: SpineX Receives NIH SBIR Phase II Award for SCiP Clinical Trial in Children With CP
- Sep 19, 2023: Onward Medical Reports 2023 Half Year Results and Business Update
- Sep 18, 2023: New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy
- Sep 06, 2023: Mainstay Medical Announces Issuance of Statement from the International Society for the Advancement of Spine Surgery (ISASS) on Restorative Neurostimulation
- Sep 05, 2023: ONWARD Schedules Webcast to Provide Half Year 2023 Business Update
- Aug 30, 2023: Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8 in the United States
- Aug 28, 2023: Medtronic's spinal cord stimulator receives CE Mark
- Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
- Aug 16, 2023: New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy
- Aug 10, 2023: Nevro Announces Launch Of HFX Connect In Europe And CE Marking Of Expanded Labelling For The HFX SCS System
- Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
- Aug 07, 2023: Tiny, Flexible Spinal Probe System Could Lead to Better Therapies
- Aug 04, 2023: Saluda Medical Announces Publication of Favorable Economic Analysis Demonstrating Cost-Dominance of Evoke(R) Closed-Loop SCS over Open-Loop SCS
- Jul 27, 2023: Soin tests TunedTX platform using low-frequency stimulation on humans
- Jul 27, 2023: Leading Medtech Company Spinex Releases Groundbreaking Results of New Cerebral Palsy Therapies
- Jul 20, 2023: Mainstay Medical Announces Publication of Three-Year Clinical Trial Data from Post-Market Clinical Follow-up Registry of ReActiv8 in the United Kingdom
- Jul 20, 2023: Nalu Medical, Presents Important New Clinical Data for PNS and SCS at ASPN 2023
- Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
- Jul 13, 2023: Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference
- Jul 13, 2023: Medtronic Shares Impact of Medicare Coverage Updates That Now Allow Nationwide Access to Spinal Cord Stimulation Therapy for the Treatment of Painful Diabetic Peripheral Neuropathy
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.